VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MRVI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MRVIMaravai LifeSciences Holdings, Inc.
$5.92$859M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMRVIQuarterly Financials

Maravai LifeSciences Holdings, Inc. (MRVI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Maravai LifeSciences Holdings, Inc. (MRVI) quarterly income statement — complete revenue, gross profit & net income history

MRVI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue65.84M49.87M41.63M47.4M46.85M56.41M65.2M73.4M64.18M74.14M66.86M68.91M79.03M204.71M191.26M242.73M244.29M228.44M204.81M217.78M
Revenue Growth %40.53%-11.59%-36.15%-35.43%-27%-23.92%-2.49%6.51%-18.79%-63.78%-65.04%-71.61%-67.65%-10.39%-6.61%11.46%64.83%132.27%133.11%-
Cost of Goods Sold32.14M37.62M35.98M39.63M39.13M37.44M36.83M38.27M38.34M35.11M36.69M43.27M33.68M53.25M38.18M37.5M40.03M40.63M32.22M37.81M
COGS % of Revenue48.81%75.45%86.42%83.61%83.51%66.38%56.48%52.14%59.73%47.35%54.87%62.79%42.61%26.01%19.96%15.45%16.39%17.79%15.73%17.36%
Gross Profit33.7M12.24M5.66M7.77M7.72M18.96M28.37M35.13M25.84M39.03M30.18M25.64M45.35M151.46M153.09M205.24M204.26M187.81M172.59M179.96M
Gross Margin %51.19%24.55%13.58%16.39%16.49%33.62%43.52%47.86%40.27%52.65%45.13%37.21%57.39%73.99%80.04%84.55%83.61%82.21%84.27%82.64%
Gross Profit Growth %336.26%-35.44%-80.07%-77.89%-70.11%-51.42%-5.98%37%-43.01%-74.23%-80.29%-87.51%-77.8%-19.36%-11.3%14.04%74.85%150.56%153.44%-
Operating Expenses31.23M18.98M-109.78M74.05M56.89M57.09M197.49M44.64M44.7M46.18M45.6M37.26M42.82M42.21M36.18M24.54M36.9M36.73M17.21M26.43M
OpEx % of Revenue47.43%38.06%-263.72%156.23%121.42%101.22%302.9%60.82%69.66%62.29%68.19%54.06%54.18%20.62%18.92%10.11%15.1%16.08%8.4%12.14%
Selling, General & Admin27.34M15.19M78.14M38.58M39.56M41.24M39.09M40.56M40.88M38.48M38.86M35.38M38.67M37.2M30.8M28.06M33.2M27.55M26.51M24.5M
SG&A % of Revenue41.52%30.47%187.7%81.39%84.45%73.12%59.95%55.25%63.7%51.9%58.12%51.33%48.94%18.17%16.1%11.56%13.59%12.06%12.94%11.25%
Research & Development3.89M3.79M9.77M4.88M4.89M4.56M4.34M5.28M5.03M4.59M4.35M4.19M4.14M5.01M5.39M4.27M3.69M9.17M1.95M1.93M
R&D % of Revenue5.91%7.6%23.47%10.3%10.43%8.09%6.66%7.2%7.84%6.2%6.5%6.09%5.25%2.45%2.82%1.76%1.51%4.02%0.95%0.89%
Other Operating Expenses00-1000K1000K1000K1000K1000K-1000K-1000K1000K1000K-1000K000-1000K00-1000K0
Operating Income2.47M-6.74M115.44M-66.28M-49.16M-38.13M-169.11M-9.51M-18.86M-7.15M-15.42M-11.61M2.53M109.25M116.9M180.7M167.37M151.09M155.38M153.53M
Operating Margin %3.76%-13.51%277.3%-139.84%-104.93%-67.6%-259.38%-12.96%-29.39%-9.64%-23.06%-16.85%3.21%53.37%61.12%74.44%68.51%66.14%75.87%70.5%
Operating Income Growth %105.03%82.33%168.26%-596.78%-160.65%-433.29%-996.93%18.1%-844.61%-106.54%-113.19%-106.43%-98.49%-27.69%-24.76%17.69%83.54%383.55%239.84%-
EBITDA15.45M8M131.28M-50.89M-34.25M-23.6M-155.07M5.04M-5.11M5.83M-2.32M184K13.44M119.28M126.81M189.61M176.62M154.53M163.38M163.7M
EBITDA Margin %23.47%16.03%315.35%-107.37%-73.11%-41.85%-237.85%6.86%-7.96%7.86%-3.47%0.27%17.01%58.26%66.3%78.11%72.3%67.64%79.77%75.17%
EBITDA Growth %145.11%133.87%184.66%-1110.76%-570.56%-504.87%-6581.39%2636.41%-138.01%-95.11%-101.83%-99.9%-92.39%-22.81%-22.38%15.83%81.18%315.74%211.85%-
D&A (Non-Cash Add-back)12.98M14.73M15.84M15.39M14.91M14.53M14.04M14.55M13.75M12.98M13.1M11.8M10.91M10.03M9.91M8.91M9.26M3.44M8M10.16M
EBIT2.47M-56.45M-38.3M-67.31M-45.91M-35.24M-162.01M-4.99M-11.54M671.59M-8.93M-6.34M7.31M106.06M116.9M179.43M169.5M148.25M158.7M153.53M
Net Interest Income-3.88M-4.17M8.46M-3.79M-3.55M-5.23M-6.56M-4.85M-3.65M-7.94M-4.21M-231K-5.79M-7.84M-3.14M-4.43M-2.66M-4.43M-7.68M-7.65M
Interest Income1.87M2.38M15.31M3.03M3.23M6.04M7.07M7.09M7.21M7.46M7.43M6.79M6.04M2.34M000000
Interest Expense5.75M6.55M6.84M6.82M6.78M11.26M13.63M11.94M10.86M15.4M11.64M7.02M11.83M10.18M3.14M4.43M2.66M4.43M7.68M7.65M
Other Income/Expense-9M-56.27M-160.59M-7.85M-3.53M-8.37M-6.53M-7.42M-3.55M663.34M-5.15M-1.75M-7.06M-13.37M-3.14M-5.71M-525K-7.26M-4.36M-7.65M
Pretax Income-6.53M-63.01M-45.15M-74.13M-52.69M-46.5M-175.64M-16.93M-22.41M656.19M-20.56M-13.36M-4.52M95.88M113.76M174.99M166.84M143.82M151.02M145.88M
Pretax Margin %-9.92%-126.36%-108.45%-156.39%-112.47%-82.44%-269.39%-23.06%-34.92%885.05%-30.75%-19.39%-5.72%46.83%59.48%72.09%68.3%62.96%73.74%66.99%
Income Tax-151K6K-92K-4.29M162K-7K311K-2.44M271K766.17M-5.46M-1.42M-3.17M8.45M14.11M18.27M19.98M17.58M18.84M11.39M
Effective Tax Rate %2.31%-0.01%0.2%5.78%-0.31%0.02%-0.18%14.39%-1.21%116.76%26.56%10.63%70.2%8.81%12.4%10.44%11.98%12.22%12.48%7.8%
Net Income-3.73M-35.68M-25.56M-39.59M-29.95M-26.14M-99.04M-7.58M-12.08M-105.96M-6.46M-6.54M-67K37.63M44.47M71.24M66.86M55.44M53.96M49.14M
Net Margin %-5.67%-71.55%-61.39%-83.53%-63.92%-46.35%-151.9%-10.33%-18.82%-142.92%-9.66%-9.49%-0.08%18.38%23.25%29.35%27.37%24.27%26.35%22.57%
Net Income Growth %87.53%-36.47%74.2%-421.96%-147.93%75.33%-1432.62%-15.96%-17926.87%-381.55%-114.53%-109.18%-100.1%-32.12%-17.59%44.96%189.42%322.38%38.54%-
Net Income (Continuing)-6.38M-63.02M-45.06M-69.84M-52.85M-46.49M-175.96M-14.49M-22.68M-109.98M-15.1M-11.94M-1.35M87.43M99.65M156.72M146.86M126.24M132.18M134.5M
Discontinued Operations00000000000000000000
Minority Interest157.52M160.33M186.42M202.12M229.66M251.92M267.99M339.48M366.73M373.13M372.99M377.07M379.12M360.02M337.91M317.2M271.74M229.86M150.98M139.22M
EPS (Diluted)-0.03-0.25-0.18-0.27-0.21-0.18-0.70-0.06-0.09-0.80-0.05-0.05-0.010.660.761.281.200.420.440.44
EPS Growth %87.86%-38.89%74.29%-383.87%-130.01%77.5%-1328.57%-12.5%-795.1%-221.21%-106.45%-103.88%-100.85%57.14%72.73%190.91%400%90.91%0%-
EPS (Basic)-0.03-0.25-0.18-0.27-0.21-0.18-0.70-0.06-0.09-0.80-0.05-0.05-0.010.660.761.191.120.420.460.44
Diluted Shares Outstanding146.43M145.07M144.68M144.24M143.43M139.73M141.56M135.84M132.33M132.14M131.93M131.86M131.74M131.65M131.65M121.97M121.97M121.97M121.97M112.28M
Basic Shares Outstanding146.43M145.07M144.68M144.24M143.43M141.81M141.56M135.84M132.33M132.14M131.93M131.86M131.74M131.63M131.54M131.5M131.5M131.46M118.43M112.2M
Dividend Payout Ratio--------------------